Drug Shortage Report for COLESTID GRANULES
| Report ID | 135849 |
| Drug Identification Number | 00642975 |
| Brand name | COLESTID GRANULES |
| Common or Proper name | Colestid 5g |
| Company Name | PFIZER CANADA ULC |
| Market Status | DORMANT |
| Active Ingredient(s) | COLESTIPOL HYDROCHLORIDE |
| Strength(s) | 5G |
| Dosage form(s) | GRANULES |
| Route of administration | ORAL ORAL |
| Packaging size | Pouch 30's |
| ATC code | C10AC |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-03-17 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-01-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2021-03-17 | English | Compare |
| v2 | 2021-03-17 | French | Compare |
| v3 | 2021-03-18 | English | Compare |
| v4 | 2024-01-30 | English | Compare |
Showing 1 to 4 of 4